348 related articles for article (PubMed ID: 10201082)
1. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.
Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082
[TBL] [Abstract][Full Text] [Related]
2. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
[TBL] [Abstract][Full Text] [Related]
3. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
[TBL] [Abstract][Full Text] [Related]
4. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
[TBL] [Abstract][Full Text] [Related]
5. [Use of multilayer perception artificial neutral networks for the prediction of the probability of malignancy in adnexal tumors].
Smoleń A; Czekierdowski A; Stachowicz N; Kotarski J
Ginekol Pol; 2003 Sep; 74(9):855-62. PubMed ID: 14674136
[TBL] [Abstract][Full Text] [Related]
6. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
7. Sonographic prediction of malignancy in adnexal masses using an artificial neural network.
Tailor A; Jurkovic D; Bourne TH; Collins WP; Campbell S
Br J Obstet Gynaecol; 1999 Jan; 106(1):21-30. PubMed ID: 10426255
[TBL] [Abstract][Full Text] [Related]
8. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
[TBL] [Abstract][Full Text] [Related]
9. A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.
Timmerman D; Bourne TH; Tailor A; Collins WP; Verrelst H; Vandenberghe K; Vergote I
Am J Obstet Gynecol; 1999 Jul; 181(1):57-65. PubMed ID: 10411796
[TBL] [Abstract][Full Text] [Related]
10. Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis.
Tailor A; Jurkovic D; Bourne TH; Collins WP; Campbell S
Ultrasound Obstet Gynecol; 1997 Jul; 10(1):41-7. PubMed ID: 9263422
[TBL] [Abstract][Full Text] [Related]
11. An improved risk of malignancy index in diagnosis of adnexal mass.
Wang LM; Song H; Song X; Zhou XB
Chin Med J (Engl); 2012 Feb; 125(3):533-5. PubMed ID: 22490416
[TBL] [Abstract][Full Text] [Related]
12. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
[TBL] [Abstract][Full Text] [Related]
13. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
14. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adnexal masses with three-dimensional ultrasonography.
Geomini PM; Kluivers KB; Moret E; Bremer GL; Kruitwagen RF; Mol BW
Obstet Gynecol; 2006 Nov; 108(5):1167-75. PubMed ID: 17077239
[TBL] [Abstract][Full Text] [Related]
16. Color and pulsed Doppler sonography, gray-scale imaging, and serum CA 125 in the assessment of adnexal disease.
Predanic M; Vlahos N; Pennisi JA; Moukhtar M; Aleem FA
Obstet Gynecol; 1996 Aug; 88(2):283-8. PubMed ID: 8692517
[TBL] [Abstract][Full Text] [Related]
17. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.
Testa AC; Timmerman D; Van Belle V; Fruscella E; Van Holsbeke C; Savelli L; Ferrazzi E; Leone FP; Marret H; Tranquart F; Exacoustos C; Nazzaro G; Bokor D; Magri F; Van Huffel S; Ferrandina G; Valentin L
Ultrasound Obstet Gynecol; 2009 Dec; 34(6):699-710. PubMed ID: 19924735
[TBL] [Abstract][Full Text] [Related]
18. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
[TBL] [Abstract][Full Text] [Related]
19. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
20. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
